Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
Jérémy Goc, Mengze Lv, Nicholas J. Bessman, Anne-Laure Flamar, Sheena Sahota, Hiroaki Suzuki, Fei Teng, Gregory Putzel, Gérard Eberl, David R. Withers, Janelle C. Arthur, Manish A. Shah, Gregory F. Sonnenberg
Topics & Concepts
BiologyInnate lymphoid cellImmunologyImmunotherapyCancer immunotherapyImmunityImmune systemTumor microenvironmentAcquired immune systemCancerMajor histocompatibility complexCancer researchGeneticsIL-33, ST2, and ILC PathwaysImmune Cell Function and InteractionEosinophilic Esophagitis